Featured Research

from universities, journals, and other organizations

Protein Predicts Prognosis For Breast Cancer Patients

Date:
January 18, 2000
Source:
University Of Chicago Medical Center
Summary:
Low levels of a protein that helps link cells together appears to be the single most effective factor for predicting which patients with early breast cancer will need chemotherapy following surgery, report researchers from the University of Chicago Medical Center in the January 15, 2000, issue of Cancer Research.

Low levels of a protein that helps link cells together appears to be the single most effective factor for predicting which patients with early breast cancer will need chemotherapy following surgery, report researchers from the University of Chicago Medical Center in the January 15, 2000, issue of Cancer Research.

Related Articles


The researchers -- studying women with node-negative breast cancer, the small, early tumors sought by mammography -- found that by adding E-cadherin to other biomarkers that they have studied they are able to distinguish those patients with a 90 percent long-term survival from those whose survival is only 44 percent.

"We found that, for women with no affected lymph nodes, E-cadherin is the strongest prognostic factor for a poor long-term outcome," said first author Ruth Heimann, M.D., Ph.D., assistant professor of radiation and cellular oncology at the University of Chicago. "Our anaylsis suggests that biomarkers like E-cadherin are even more important than tumor size, tumor grade, the presence of estrogen receptors or the age of the patient."

It is not the original breast cancer that kills women but the tumor's spread to other sites. Surgeons can remove the initial tumor, radiation therapy is effective in treating disease that has reached nearby lymph nodes, and chemotherapy can decrease the risk of distant metastases. But chemotherapy is not always effective and has significant side effects. Only 20 to 30 percent of women with node-negative breast cancer will develop metastatic disease. If physicians could predict who was at risk they could increase the intensity of chemotherapy for those women and reduce or even eliminate the therapy and its side effects for those not at risk.

Unfortunately, the standard tools for assessing risk of metastasis -- such as the size of the tumor, its grade, the presence of estrogen receptors and the proportion of dividing cells -- are "insufficient," note the authors, "for clinical decision making."

So Heimann and her colleagues have spent years looking for better "biomarkers," proteins found at varying levels in early breast cancers, which can provide clues about whether the cancer is likely to have spread.

The focal point for this search is a rare medical archive, a database of tissue samples and long-term follow-up information from 2,136 breast cancer patients treated with mastectomy, but not radiation or chemotherapy, at the University of Chicago between 1927 and 1987. The researchers found sufficient archival material to test the importance of several biomarkers, including E-cadherin, from 168 women with node-negative breast cancer.

A previous study (Cancer Research, July 1, 1998) found that two other markers could predict a good outcome. More than 90 percent of patients with either high nm23, a protein that prevents the cancer from spreading, or low angiogenesis, minimal growth of new blood vessels to supply the budding tumor, were alive an average of 14 years after treatment, compared to only 70 percent of those with low nm23 or high vessel density.

High or intermediate levels of E-cadherin add little assurance of good prognosis, but abnormally low levels of this protein indicate a substantially increased risk of metastasis.

The authors argue that the loss of E-cadherin is a later but crucially important step in the long progression from normal to highly malignant tissue. The growth of new blood vessels tends to occur quite early for most cancers; even small tumors found via mammogram frequently have a high microvessel count (MVC). However, patients with high MVC combined with high protective levels of nm23 also do quite well, 90 percent surviving 14 years.

Loss of nm23 is more significant and appears to occur slightly later. Fourteen-year disease-free survival falls to 69 percent for patients who have a high microvessel count combined with low nm23, but still have high or moderate E-cadherin levels.

The loss of E-cadherin is a an additional and still later step toward malignancy. Only 44 percent of breast cancer patients with a high microvessel count, low nm23 and low E-cadherin levels are alive and disease free 14 years after surgery.

The mechanism of how E-cadherin prevents tumor spread is unclear. The protein is involved in cell-cell adhesion. It also acts to suppress the invasive character of cancer cells. As cancerous cells become more invasive they produce less E-cadherin.

"The additional information we can now derive from tumor biomarkers such as E-cadherin, nm23 and microvessel counts should begin to allow us to tailor therapy according to individual tumor types," added Samuel Hellman, M.D., A.N. Pritzker Distinguished Service Professor of radiation and cellular oncology at the University of Chicago and co-author of the paper.

"Two thirds of node-neagative patients will never develop metastases, even with out chemotherapy. As we find more and more biomarkers that can predict which patients those will be, we can eliminate the unnecessary morbidity caused by treating patients who are well and perhaps increase the intensity of therapy in patients who are at high risk for metastatic disease."

Fusheng Lan and Russell McBride, both from the University of Chicago, also contributed to the study.


Story Source:

The above story is based on materials provided by University Of Chicago Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Chicago Medical Center. "Protein Predicts Prognosis For Breast Cancer Patients." ScienceDaily. ScienceDaily, 18 January 2000. <www.sciencedaily.com/releases/2000/01/000118063016.htm>.
University Of Chicago Medical Center. (2000, January 18). Protein Predicts Prognosis For Breast Cancer Patients. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/2000/01/000118063016.htm
University Of Chicago Medical Center. "Protein Predicts Prognosis For Breast Cancer Patients." ScienceDaily. www.sciencedaily.com/releases/2000/01/000118063016.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Christmas Kissing Good for Health

Christmas Kissing Good for Health

Reuters - Innovations Video Online (Dec. 22, 2014) Scientists in Amsterdam say couples transfer tens of millions of microbes when they kiss, encouraging healthy exposure to bacteria. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Brain-Dwelling Tapeworm Reveals Genetic Secrets

Brain-Dwelling Tapeworm Reveals Genetic Secrets

Reuters - Innovations Video Online (Dec. 22, 2014) Cambridge scientists have unravelled the genetic code of a rare tapeworm that lived inside a patient's brain for at least four year. Researchers hope it will present new opportunities to diagnose and treat this invasive parasite. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins